CXCR4 and head and neck squamous cell carcinoma: This effect was demonstrated in vitro in two different HNSCC cell lines, showing that only CXCR4+ cells are killed by the nanotoxins and also by the demonstration of a complete cell death blockade by AMD3100 (CXCR4 antagonist) exposure prior to nanotoxins treatment.